AU Patent

AU3043601A — Use of pyrimidine endothelin antagonists in companion animals

Assigned to Pfizer Inc · Expires 2001-08-20 · 25y expired

What this patent protects

Compound of formula (I) where the substituents have the values described herein, are useful in combatting endothelin-mediated disorders in companion animals, especially dogs, cats and horses.

USPTO Abstract

Compound of formula (I) where the substituents have the values described herein, are useful in combatting endothelin-mediated disorders in companion animals, especially dogs, cats and horses.

Drugs covered by this patent

Patent Metadata

Patent number
AU3043601A
Jurisdiction
AU
Classification
—
Expires
2001-08-20
Drug substance claim
No
Drug product claim
No
Assignee
Pfizer Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.